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SUMMARY
The global problem of antibiotic resistance is 
threatening us. Since 2001, the proportion of 
methicillin-resistant Staphylococcus aureus 
(MRSA) infections in the community has 
doubled.
As one of the highest users of antibiotics in 
the developed world, Australia needs a more 
judicious approach to antibiotic use.
Antimicrobial stewardship programs, which 
aim to improve the appropriate use of 
antibiotics and reduce antibiotic resistance, 
have been shown to be effective in Australian 
hospitals. 
Antimicrobial stewardship needs to be 
extended to the community where the 
greatest proportion of antibiotics are 
prescribed. Antibiotic restriction, education 
of prescribers and patients and prescribing 
feedback have already had some success.
unless action is taken now to preserve antibiotic 
effectiveness into the future.
The factors leading to bacterial resistance are 
complex and multifactorial. Along with infection 
control and surveillance, antimicrobial stewardship 
aims to reduce inappropriate use of antibiotics and 
improve patient outcomes.
Antibiotic use and resistance in 
Australia
Australia is one of the highest users of antibiotics 
in the developed world, with around 22 million 
prescriptions written every year in primary care. The 
defined daily dose in Australia is nearly 23/1000 
population/day compared with less than 15 for 
Denmark, the Netherlands and Sweden (Fig. 1).2-5
In hospitals
The federally-funded National Antimicrobial Utilisation 
Surveillance Program monitors antibiotic use in 
hospitals. It provides reports every two months on 
inpatient use, which enables analysis of trends and 
comparison of usage between hospitals.
In the community
Estimating antibiotic use in the community is 
more difficult. It is based on a combination of 
Pharmaceutical Benefits Scheme and Repatriation 
Pharmaceutical Benefits Scheme reimbursement data, 
along with estimates of non-subsidised medicines 
obtained from surveying a representative sample of 
community pharmacies. 
General practitioners prescribe the greatest 
proportion of antibiotics in Australia, mostly for acute 
respiratory tract infections. Antibiotics remain the 
most common class of medicine prescribed in general 
practice. 
Resistant organisms are increasing in the community. 
These require treatment with antibiotics such as 
vancomycin, carbapenems and fluroquinolones, which 
Introduction
Much of the advancement in modern medicine 
has been made possible through access to safe 
and effective antibiotics. Although they remain 
the mainstay of treatment for infectious diseases, 
antibiotics are not effective against most acute 
respiratory infections, which are usually caused by 
viruses.
The pipeline of new antibiotics has almost completely 
dried up and use of the antibiotics we have will 
inevitably lead to resistance. Antibiotic-resistant 
pathogens found in Australia include:
 • methicillin-resistant Staphylococcus aureus 
(MRSA)
 • multi-resistant Streptococcus pneumoniae
 • vancomycin-resistant enterococci
 • multi-resistant Escherichia coli and other 
enterobacteriaceae. 
Patients who acquire an antibiotic-resistant infection 
stay in hospital longer and have higher morbidity and 
mortality.1 The World Health Organization refers to 
antibiotic resistance as one of the greatest threats to 
human health. The world is facing a global disaster 
Antimicrobial stewardship:  
what’s it all about?  
Antimicrobial stewardship is a collective set of strategies 
to improve the appropriateness and minimise the adverse 
effects of antibiotic use including resistance, toxicity and 
costs. Stewardship is achieved by promoting the selection 
of the optimal antibiotic regimen, dose, duration and route 
of administration.
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or are currently in the process of implementing 
stewardship programs. Guidelines for implementing 
antimicrobial stewardship in Australian hospitals have 
been published.12
Programs must be adequately resourced and 
supported by hospital management. In large hospitals, 
antimicrobial stewardship is generally driven by a 
multidisciplinary team led by a clinician (usually an 
infectious diseases physician or clinical microbiologist) 
and a pharmacist, ideally with specialised training in 
infectious diseases. Teams work collaboratively within 
the hospital to implement the program (Box 1).
Several measures are used to assess the success of 
programs including antibiotic use, expenditure and 
antibiotic resistance. One proposed outcome indicator 
is the incidence of C. difficile infection.8,12
An antimicrobial stewardship program was launched 
at the Royal Hobart Hospital in May 2009. The 
following activities were included in the program:
 • formulation of guidelines
 • the use of a computer-based antibiotic restriction 
and approval program
 • regular infectious diseases ward rounds on the 
intensive care and oncology units
 • daily stewardship ward rounds providing feedback 
to antibiotic prescribers. 
In the first 12 months, spending on antibiotics was 
reduced by 30% (approximately $300 000), along 
with a 20% reduction in prescribing of broad-spectrum 
antibiotics such as ceftriaxone and meropenem. 
are often used when all other antibiotics have failed. 
For example between 2001 and 2010, the incidence of 
MRSA in the community doubled from 10 to 20% of all 
reported S. aureus infections.6 In Tasmania, a recent 
increase in Clostridium difficile – an infection closely 
correlated with antibiotic use – was observed.7 This 
was most likely linked to transmission and infection 
pathways in the community, not within hospitals, 
and was driven substantially by antibiotic use in the 
community.8 
On a more positive note, when the selective pressure 
of antibiotics is removed, resistance can be reversed.9 
In the 12 months following antibiotic cessation in 
individual patients in the community, resistance fades 
towards zero.10 
Antimicrobial stewardship in 
hospitals
Antimicrobial stewardship programs in hospitals 
have been shown to reduce inappropriate antibiotic 
use by 22–36%. Programs improve patient outcomes 
and reduce adverse consequences of antibiotic 
use, including antibiotic resistance, toxicity and 
unnecessary costs.11 
Since 2011, antimicrobial stewardship has been 
included in the Australian Commission on Safety 
and Quality in Health Care’s National Safety and 
Quality Health Service Standards for hospitals and 
is one of the compulsory criteria of the hospital 
accreditation process. The majority of hospitals in 
Australia, including smaller regional facilities, have 
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Fig. 1    Comparison of Australian and European antibiotic use in the community  
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Antimicrobial stewardship in the 
community
Clearly antimicrobial stewardship needs to be 
extended to where the greatest use occurs.14 Three 
principal strategies are already in place in the 
community. These are antibiotic restriction, prescriber 
and patient education and post-prescribing feedback 
(Box 2). 
These strategies have had some success. General 
practitioner antibiotic prescribing for acute respiratory 
tract infections significantly decreased between  
2000 and 2005. However, since 2005 there has  
been little change (Fig. 2).16 This may be driven by 
consumer expectation – an NPS MedicineWise survey  
found that four in five Australians expected a 
prescription when they have an ear, nose, throat or 
chest infection.* Accordingly, in February 2012, NPS 
MedicineWise launched a five-year campaign against 
antibiotic resistance with a strong emphasis on 
community education.17
Proposed activities for the 
community 
One approach could be to establish antimicrobial 
stewardship teams in the community. These could 
align with NPS MedicineWise to promote the 
quality use of antibiotics in the community. Teams 
could work out of Medicare Locals and residential 
aged-care facilities providing regular, ongoing NPS 
MedicineWise-endorsed education for prescribers 
and consumers, coordinated research, data collection 
and feedback (for example point prevalence surveys 
and clinical audits). In the future these teams might 
be guided by clinical standards for the quality use 
of antibiotics, set by the Australian Commission on 
Safety and Quality in Health Care’s National Safety 
and Quality Health Service Standards for hospitals.
The teams could provide further focus on: 
 • delayed prescriptions – these are antibiotic 
prescriptions with instruction to the patient 
that they should only fill the antibiotic if they 
deteriorate.18 This effectively reduces antibiotic use 
without causing anxiety for the patient or doctor19
 • hand hygiene to reduce the spread of respiratory 
and other pathogens20
 • alternatives to antibiotics – these include analgesics 
or decongestants for acute respiratory infections,21 
topical treatments for the pain associated with 
otitis media,22 and corticosteroids23,24 all of which 
need more evaluation 
 • emphasis on the adverse effects of antibiotics 
(such as thrush, diarrhoea, nausea)  
 • improved communication with patients – the 
assumption that patients expect antibiotics is 
often incorrect, and a better shared understanding 
of the objectives of managing acute respiratory 
tract infections may well lead to fewer antibiotic 
prescriptions.21 
* www.nps.org.au/media-centre/media-releases/
repository/1-in-5-australians-expect-antibiotics-for-
coughs-or-colds-new-nps-campaign
Box 1    Strategies for antimicrobial stewardship in hospitals
Five essential strategies:
 • local prescribing guidelines based on Therapeutic Guidelines: Antibiotic13 and modified 
according to local organisms and susceptibility patterns
 • antibiotic restriction with approval systems for broad-spectrum drugs (by telephone or 
computer-based)
 • giving feedback to the prescriber
 • monitoring antibiotic prescribing data and external benchmarking
 • reporting microbiological susceptibility results in line with the institution’s restriction 
policy and treatment guidelines.
Additional activities adapted for local priorities and resources:
 • staff education (on appropriate prescribing and antibiotic resistance)
 • ward rounds (advice on treatment duration, changing empirical to directed therapy, 
appropriate dosing, and when to switch from intravenous to oral antibiotics)
 • electronic prescribing (enhancing approval and decision support systems)
 • provision of local antibiotic susceptibility data.
Box 2    Antibiotic stewardship strategies in the community
Restricting antibiotics via the Pharmaceutical Benefits Scheme 
For example, restriction of fluoroquinolones means that their use is low (see Fig. 1). This 
may have contributed to the low Australian incidence of hyper-virulent Clostridium difficile 
strains associated with fluoroquinolone resistance.
Prescriber and patient education programs 
Interventions combining doctor, patient and public education are the most successful at 
reducing inappropriate antibiotic prescribing for acute respiratory tract infections15
NPS MedicineWise:
 • past programs have targeted overprescribing of antibiotics for acute respiratory tract 
infections and asymptomatic bacteriuria
 • online learning modules on antibiotic prescribing 
 • individual academic detailing for general practitioners and pharmacists 
 • group discussions and case studies for the whole primary care team 
 • symptomatic management pads offer alternatives to antibiotics for acute respiratory 
tract infections
Prescribing feedback 
NPS MedicineWise:
 • prescribing rates sent to individual general practitioners allowing comparison with local 
and national averages 
 • tools provided for practices to perform clinical audits on antibiotic use
Antimicrobial stewardship: what’s it all about?
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Conclusion
Antimicrobial stewardship in hospitals reduces the 
inappropriate use and consequences of antibiotics 
and improves patient outcomes. Aspects of 
stewardship are already in place in the community. 
Many of these are led by NPS MedicineWise. Adopting 
novel stewardship strategies in the community could 
provide a systematic approach to the growing threat 
of antibiotic resistance. 
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Fig. 2    Antibiotic prescribing for upper respiratory tract infections (URTIs)  
in Australia 1998–2010 
Adapted and reproduced with permission from the Australian Institute of Health and Welfare16 
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Dental note 
Antimicrobial stewardship 
Dentists should be aware that the prescription of 
antibiotics needs to be judicious, especially with 
growing concerns about antibiotic resistance.  
According to the Department of Health and 
Ageing, dentists account for about 3% of antibiotic 
prescribing. Dentists therefore contribute to antibiotic 
use within the community and play a role in the 
development of antimicrobial resistance. In Australia1 
and overseas2 dentists have been found to over-
prescribe antibiotics, particularly penicillins, as part of 
dental treatment. Antibiotics may be inappropriately 
prescribed for dental pain when operative dental 
treatment is the appropriate management.2 An 
essential strategy to avoid inappropriate antibiotics or 
inappropriate dose and duration is use of prescribing 
guidelines such as Therapeutic Guidelines: Antibiotic.3
Dentists can contribute to community education 
about antibiotic resistance and can also reinforce 
the message of the NPS MedicineWise campaign4 
about using antibiotics only when indicated, by 
discussing these matters with their patients. However, 
the most important contribution that dentists can 
make in terms of judicious use of antibiotics is to 
follow prescribing guidelines. In Australia, these 
are presented in Therapeutic Guidelines: Oral and 
Dental.5 These guidelines state in part: ‘It must first 
be determined if an antimicrobial drug is needed. The 
majority of infections that present in the dental clinic 
require active dental treatment to remove the source 
of infection, and this is usually the most effective 
method of treating the problem.’ 
Specific guidelines3,5 have been developed for 
antibiotic prophylaxis in the dental setting. The 
guidelines for antibiotic prophylaxis for the prevention 
of infective endocarditis were updated in Australia 
in 2008 and limit the number of conditions which 
require antibiotic cover.3,5 Patients with mitral valve 
prolapse no longer require antibiotic cover for 
dental treatment. For patients with joint prostheses, 
the value of antibiotic prophylaxis has not been 
demonstrated. Prophylaxis is not recommended when 
the risks of adverse reactions outweigh its benefits.3
Antibiotics should not be prescribed unnecessarily as 
part of dental treatment. When they are indicated, 
dentists should follow the published recommendations 
for antibiotic selection, dose and duration.5
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